Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Hank who wrote (4145)	5/13/1998 10:09:00 PM
From: phbolton	Read Replies (1) \| Respond to of 7041

This week's New England Journal of Medicine (May 14) has a lead article on viagra and an accompanying editorial. Take a look to see some peer reviewed information on what zona is attempting to compete with. Compare this information with anything in the literature on phentolamine and decide for yourself. brief summary: 69% of attempts at intercourse successful (that is different than erections) vs 22% with placebo, 5.9 times/month vs 1.5 with placebo; average/mean age of patients in late 50s, almost no effect on "sexual desire", surprisingly (to me) low effect- about 50% gain- on "intercourse satisfaction", the editorial is very positive